Trials / Conditions / Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive

5 registered clinical trials studyying Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive.

Status	Trial	Sponsor	Phase
Terminated	Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HS NCT02728700	Stanford University	Phase 1
Completed	Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia NCT01445080	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease i NCT00105001	Fred Hutchinson Cancer Center	Phase 2
Completed	Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With NCT00898079	Children's Oncology Group	—
Completed	Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by NCT00003145	Fred Hutchinson Cancer Center	Phase 2